Davidson Kempner Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,150,122
Closed -$809M 224
2019
Q3
$809M Buy
8,150,122
+511,105
+7% +$48.6M 15.9% 1
2019
Q2
$706M Buy
7,639,017
+3,500,479
+85% +$332M 7.66% 5
2019
Q1
$390M Buy
+4,138,538
New +$362M 7.49% 2
2014
Q1
Sell
-135,800
Closed -$11.5M 192
2013
Q4
$11.5M Buy
+135,800
New +$10.7M 0.41% 57

Other funds holding CELG

Davidson Kempner Capital Management's CELG Position: Q4 2019 in Review

Davidson Kempner Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,150,122 shares — an estimated $809M sold.

Davidson Kempner Capital Management first reported a position in CELG in Q4 2013 and held it in 4 quarters. The position peaked at $809M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Davidson Kempner Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 8,150,122 Celgene Corp shares in Q4 2019, an estimated $809M.
  • Davidson Kempner Capital Management first reported a position in Celgene Corp in Q4 2013 and held it in 4 quarters.
  • Davidson Kempner Capital Management's Celgene Corp position peaked at $809M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.